Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial

Go back to Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
(NASDAQ: SLDB) Delayed: 9.47 +0.18 (1.94%)
Previous Close $9.29    52 Week High
Open $9.26    52 Week Low
Day High $9.52    P/E N/A 
Day Low $9.13    EPS
Volume 1,789,276